These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20940407)

  • 1. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
    Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I
    Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer.
    Funakoshi T; Tachibana I; Hoshida Y; Kimura H; Takeda Y; Kijima T; Nishino K; Goto H; Yoneda T; Kumagai T; Osaki T; Hayashi S; Aozasa K; Kawase I
    Oncogene; 2003 Feb; 22(5):674-87. PubMed ID: 12569360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cells.
    Saito Y; Tachibana I; Takeda Y; Yamane H; He P; Suzuki M; Minami S; Kijima T; Yoshida M; Kumagai T; Osaki T; Kawase I
    Cancer Res; 2006 Oct; 66(19):9557-65. PubMed ID: 17018612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
    Hartmann TN; Burger JA; Glodek A; Fujii N; Burger M
    Oncogene; 2005 Jun; 24(27):4462-71. PubMed ID: 15806155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets.
    Furuya M; Kato H; Nishimura N; Ishiwata I; Ikeda H; Ito R; Yoshiki T; Ishikura H
    Cancer Res; 2005 Apr; 65(7):2617-25. PubMed ID: 15805258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of adhesion molecules and chemokine receptor CXCR4 (CD184) in small cell lung cancer.
    Hartmann TN; Burger M; Burger JA
    J Biol Regul Homeost Agents; 2004; 18(2):126-30. PubMed ID: 15471215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.
    Burger M; Glodek A; Hartmann T; Schmitt-Gräff A; Silberstein LE; Fujii N; Kipps TJ; Burger JA
    Oncogene; 2003 Nov; 22(50):8093-101. PubMed ID: 14603250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo.
    Sethi T; Rintoul RC; Moore SM; MacKinnon AC; Salter D; Choo C; Chilvers ER; Dransfield I; Donnelly SC; Strieter R; Haslett C
    Nat Med; 1999 Jun; 5(6):662-8. PubMed ID: 10371505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer.
    Higashiyama M; Taki T; Ieki Y; Adachi M; Huang CL; Koh T; Kodama K; Doi O; Miyake M
    Cancer Res; 1995 Dec; 55(24):6040-4. PubMed ID: 8521390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
    Guo L; Zhou Y; Sun Y; Zhang F
    Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
    Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
    Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
    Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
    Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells.
    Murayama Y; Shinomura Y; Oritani K; Miyagawa J; Yoshida H; Nishida M; Katsube F; Shiraga M; Miyazaki T; Nakamoto T; Tsutsui S; Tamura S; Higashiyama S; Shimomura I; Hayashi N
    J Cell Physiol; 2008 Jul; 216(1):135-43. PubMed ID: 18247373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment.
    Martínez-García E; Irigoyen M; González-Moreno O; Corrales L; Teijeira A; Salvo E; Rouzaut A
    Toxicol Sci; 2010 Aug; 116(2):467-76. PubMed ID: 20457658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
    Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia.
    Yamazaki H; Xu CW; Naito M; Nishida H; Okamoto T; Ghani FI; Iwata S; Inukai T; Sugita K; Morimoto C
    Biochem Biophys Res Commun; 2011 May; 409(1):14-21. PubMed ID: 21549094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
    Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
    Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix regulation of drug resistance in small-cell lung cancer.
    Rintoul RC; Sethi T
    Clin Sci (Lond); 2002 Apr; 102(4):417-24. PubMed ID: 11914104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.